The Journal of Organic Chemistry
Article
CDCl3) 171.9, 171.7, 171,2, 156.0, 136.0, 127.4, 123.3, 122.0, 119.4,
118.3, 111.3, 109.3, 80.2, 52.6, 52.3, 51.4,, 30.4, 28.2, 27.4, 24.5, 22.8,
17.3; MALDI TOF/TOF m/z calcd for C28H42N4NaO6 (M + Na) is
553.3002, obsd 553.3280.
127.4, 80.1, 50.2, 43.4, 28.3, 18.5; MALDI TOF/TOF m/z calcd for
C15H22N2O3 (M + Na) is 301.1528, obsd 301.1804.
Boc-Ser(OtBu)-Trp-OMe (P13): gummy (1.94 g, 65%); H NMR
1
(400 MHz; CDCl3) δ 8.331 (br, 1H), 7.55 (d, J = 8 Hz, 1H), 7.34 (d, J
= 8 Hz, 1H), 7.31 (br, 1H), 7.17 (t, J = 7.2 Hz, 1H), 7.11 (t, J = 6.8
Hz, 1H), 7.01 (d, J = 1 Hz, 1H), 5.42 (d, J = 5.2 Hz, 1H), 4.5 (m, 1H),
4.18 (br, 1H), 3.75 and 3.37 (dd, 2H), 3.30 (br, 2H), 3.63 (s, 3H),
1.42 (s, 9H), 1.11 (s, 9H); 13C NMR (100 MHz, CDCl3) 172.0, 170.3,
155.5, 136.1, 127.6, 123.0, 122.2, 119.6, 118.7, 111.3, 109.9, 80.0, 74.0,
61.8, 60.5, 54.2, 53.1, 52.3, 28.3, 27.3, 21.1, 14.3. MALDI TOF/TOF
m/z calcd for C24H35N3O6 (M + Na) 484.2424, obsd 484.2915.
Boc-Phe-Val-OMe (P5):35 white powder (0.279 g, 74%); [α]25
D
1
−18 (c 0.1, MeOH); H NMR (400 MHz; CDCl3) δ 7.35−7.26 (m,
5H), 6.45 (d, J = 8 Hz, 1H), 5.10 (br, 1H), 4.51 (q, J = 4 Hz, 1H), 4.4
(br, 1H), 3.74 (s, 3H), 3.12 (d, J = 8 Hz, 2H), 2.18−2.12 (m, 1H),
1.46 (s, 9H), 0.90 (dd, J =4 Hz, J = 8 Hz, 6H); 13C NMR (100 MHz;
CDCl3) δ 171.7, 171.1, 155.3, 136.5, 129.2, 128.5, 126.8, 80.1, 57.1,
55.7, 52.0, 37.9, 31.2, 28.1, 18.7, 17.6; MALDI TOF/TOF m/z calcd
for C20H30N2O5 (M + Na) 401.2052, obsd (M + Na) 401.2318.
Boc-Phe-DVal-OMe (P6):36 white powder (0.287 g, 76%); [α]25D +6
Cbz-Leu-Ala-OMe (P14):37 white powder (1.26 g, 60%); H NMR
1
(400 MHz; CDCl3) δ 7.35 (m, 5H), 6.62 (d, J = 5.6 Hz, 1H), 5.30 (d,
J = 8.4 Hz, 1H), 5.10 (s, 2H), 4.59−4.54 (m,1H), 4.26−4.20 (m,1H),
3.74 (s, 3H), 1.73−1.60 (m, 2H), 1.55−1.48 (m, 1H), 1.39 (d, J = 6.8
Hz, 3H), 0.94 (d, J = 6.4 Hz, 6H); 13C NMR (100 MHz; CDCl3)
173.1, 171.7, 156.1, 136.1, 128.5, 128.1, 128.0, 67.0, 53.3, 52,5, 48.0,
41.5, 24.6, 22.9, 22.0, 18.2; MALDI TOF/TOF m/z calcd for
C18H26N2O5 (M + Na) 373.1739, obsd 373.2563.
1
(c 0.1, MeOH); H NMR (400 MHz; CDCl3) δ 7.35−7.25 (m, 5H),
6.45 (d, J = 4 Hz, 1H), 5.06 (br, 1H), 4.51 (br, 1H), 4.45 (br, 1H),
3.75 (s, 3H), 3.12 (d, J = 8 Hz, 2H), 2.13−2.06 (m,, 1H), 1.46 (s, 9H),
0.83 (dd, J = 8 Hz, J = 8 Hz, 6H); 13C NMR (100 MHz; CDCl3) δ
171.9, 171.1, 155.3, 136.5, 129.2, 128.7, 126.9, 80.2, 57.0, 55.8, 52.1,
38.2, 31.0, 28.2, 18.7, 17.5; MALDI TOF/TOF m/z calcd for
C20H30N2O5 (M + Na) 401.2052, obsd (M + Na) 401.2291.
Crystal Structure Analysis of (Boc-Ala-S-)2 (3a). Crystals of (Boc-
Ala-CO-S-)2 were grown by slow evaporation of ethyl acetate/n-
hexane (40/60). A single crystal (0.12 × 0.07 × 0.04 mm) was
mounted in a loop with a small amount of the mother liquor. The X-
ray data were collected at 100 K using Mo Kα radiation (λ = 0.71073
Boc-Phe-Ala-OMe (P7): white powder (0.283 g, 81%); [α]25 −22
D
1
(c 0.1, MeOH); H NMR (400 MHz; CDCl3) δ 7.32−7.20 (m, 5H),
6.47 (d, J = 4 Hz, 1H), 5.03 (d, J = 8 Hz, 1H), 4.56−4.49 (m, 1H),
4.38−4.37 (m, 1H), 3.72 (s, 3H), 3.08 (t, J = 6 Hz, 2H), 1.41 (s, 9H),
1.35 (d, J = 8 Hz, 3H); 13C NMR (100 MHz; CDCl3) δ 172.8, 170.7,
155.3, 136.4, 129.3, 128.6, 126.9, 80.2, 55.5, 52.4, 48.0, 38.3, 28.2, 18.3;
MALDI TOF/TOF m/z calcd for C18H26N2O5 (M + Na) = 373.1739,
obsd (M + Na) 373.1906.
́
Å), ω-scans (2θ = 56.56°) for a total number of 3080 independent
reflections. Space group P2(1),2(1),2(1) a = 10.322(3) Å, b =
11.312(4) Å, c = 18.663(6) Å, α = 90.00°, β = 90°, γ = 90.00°, V =
2179.1(12) Å3, orthorhombic P, Z = 4 for chemical formula
C16H28N2O6S2, with one molecule in asymmetric unit; ρcalcd =1.245
g cm−3, μ = 0.275 mm−1, F(000) = 872, Rint = 0.1890. All non-
hydrogen atoms were refined anisotropically. The hydrogen atoms
were fixed geometrically in the idealized position and refined in the
final cycle of refinement as riding over the atoms to which they are
bonded. The final R value was 0.0684 (wR2 = 0.1170) for 3080
observed reflections (F0 ≥ 4σ(|F0|)) and 243 variables, S = 0.943. The
largest difference peak and hole were 0.284 and −0.341 e Å3,
respectively.
Boc-Val-Ala-Trp-OMe (P8): white powder (0.356 g, 73%); [α]25
−34 (c 0.1, MeOH); H NMR (400 MHz; CDCl3) δ 8.56 (br, 1H),
D
1
7.48 (d, J = 8 Hz, 1H), 7.33 (d, J = 8 Hz, 1H), 7.16 (t, J = 8 Hz, 1H),
7.09 (t, J = 8 Hz, 1H), 7.00 (br, 1H), 6.78 (d, J = 8 Hz, 1H), 6.69 (d, J
= 8 Hz, 1H), 5.12 (d, J = 8 Hz, 1H), 4.90−4.85 (m, 1H), 4.53−4.45
(m,1H), 3.94 (t, J = 8 Hz, 1H), 3.67 (s, 3H), 3.30 (d, J = 8 Hz, 2H),
2.06−2.00 (m, 1H), 1.45 (s, 9H), 1.32 (d, J = 8 Hz, 3H), 0.86 (dd, J =
8 Hz, J = 16 Hz, 6H); 13C NMR (100 MHz, CDCl3); 171.9, 171.8,
171.5, 136.0, 127.4, 123.3, 122.0, 119.4, 118.3, 111.3, 109.3, 80.2, 59.8,
52.8, 52.4, 48.6, 30.7, 29.6, 28.7, 19.1, 17.2; MALDI TOF/TOF m/z
calcd for C25H36N4NaO6 (M + Na) 511.2532, obsd 511.2528.
Boc-Aib-Val-OMe (P9): white powder (0.205 g, 65%); [α]25D −6 (c
0.1, MeOH); 1H NMR (400 MHz; CDCl3) δ 7.02 (br, 1H), 4.94 (br,
1H), 4.52 (q, J = 4 Hz, 1H), 3.71 (s, 3H), 2.19−2.13 (m, 1H), 1.51
and 1.47 (s, 6H), 1.43 (s, 9H), 0.92 (dd, J = 8 Hz, J = 4 Hz, 6H); 13C
NMR (100 MHz, CDCl3) 174.4, 172.4, 154.5, 80.1, 57.0, 56.8, 52.0,
31.1, 28.3, 28.2, 26.0, 18.9, 17.5; MALDI TOF/TOF m/z calcd for
C15H28N2NaO5 (M + Na) 339.1896, obsd 339.1841.
Crystal Structure Analysis of (Boc-Aib-S-)2 (3e). Crystals of (Boc-
Aib-CO-S-)2 were grown by slow evaporation of ethyl acetate/n-
hexane (40/60). A single crystal (0.1 × 0.06 × 0.03 mm) was mounted
in a loop with a small amount of the mother liquor. The X-ray data
were collected at 100 K temperature using Mo Kα radiation (λ =
́
0.71073 Å), ω-scans (2θ = 56.56°) for a total number of 6601
independent reflections. Space group Pca2(1), a = 23.375(11) Å, b =
9.575(4) Å, c = 10.580(5) Å, α = 90.00°, β = 90°, γ = 90.00°, V =
2368.1(19) Å3, orthorhombic P, Z = 4 for chemical formula
C18H32N2O6S2, with one molecule in asymmetric unit; ρcalcd = 1.225
g cm−3, μ = 0.258 mm−1, F(000) = 936, Rint = 0.0806. All non-
hydrogen atoms were refined anisotropically. The hydrogen atoms
were fixed geometrically in the idealized position and refined in the
final cycle of refinement as riding over the atoms to which they are
bonded. The final R value was 0.0386 (wR2 = 0.0680) for 6601
observed reflections (F0 ≥ 4σ(|F0|)) and 263 variables, S = 0.766. The
largest difference peak and hole were 0.205and −0.249 e Å3,
respectively.
Boc-Aib-Trp-OMe (P10): white powder (0.298 g, 74%); [α]25 +2
D
1
(c 0.1, MeOH); H NMR (400 MHz; CDCl3) δ 8.43 (br, 1H), 7.54
(d, J = 8 Hz, 1H), 7.34 (d, J = 4 Hz, 1H), 7.18−7.03 (m, 3H), 6.89 (br,
1H), 5.02 (d, J = 4 Hz, 1H), 4.91−4.85 (m, 1H), 3.63 (s, 3H), 3.36−
3.25 (m, 2H), 1.43 and 1.39 (s, 6H) and (s, 9H); 13C NMR (100
MHz, CDCl3) 174.4, 172.4, 154.5, 136.0, 127.4, 122.9, 121.9, 119.3,
118.4, 111.2, 109.7, 79.9, 56.6, 53.0, 52.2, 28.1, 27.6, 24.4; MALDI
TOF/TOF m/z calcd for C21H29N3NaO5 (M + Na) is 426.2005, obsd
426.1302.
Fmoc-Leu-Ala-Leu-OMe (P11): white powder (0.460 g, 84%);
[α]25D −50 (c 0.1, MeOH); 1H NMR (400 MHz, CDCl3) δ 7.76 (d, J
= 8 Hz, 2H), 7.58 (d, J = 8 Hz, 2H), 7.39 (t, J = 6 Hz, 2H), 7.30 (t, J =
8 Hz, 2H), 6.77 (d, J = 16 Hz, 2H), 7.30 (t, J = 8 Hz, 2H), 6.77 (d, J =
16 Hz, 2H), 5.43 (d, J = 8 Hz, 1H), 4.56 (br, 2H), 4.47−4.34 (m, 2H),
4.20 (t, J = 6 Hz, 2H), 3.71 (s, 3H), 1.62−154 (m, 6H), 1.37 (d, J = 8
Hz, 3H), 0.92 (t, J = 6 Hz, 12H); 13C NMR (100 MHz, CDCl3) 173.1,
172.2, 171.7, 156.2, 143.7, 141.3, 127.7, 127.0, 125.0, 120.0, 67.0, 54.0,
52.3, 50.8, 48.7, 47.1, 41.7, 42.3, 29.7, 24.7, 24.6, 23.0, 21.8, 18.0;
MALDI TOF/TOF m/z calcd for C31H41N3NaO6 [M + Na]
574.2893, obsd 574.3691.
ASSOCIATED CONTENT
■
S
* Supporting Information
1H NMR, 13C NMR, and mass spectra of all compounds (3a−f,
and P1−P14) and crystallographic information for compounds
3a and 3e (CIF). This material is available free of charge via the
AUTHOR INFORMATION
Corresponding Author
Notes
■
Boc-Ala-NHBn (P12):19 white solid (1.5 g, 78%); H NMR (400
1
MHz; CDCl3) δ 7.32−7.22 (m, 5H), 6.821 (br, 1H), 5.201 (br, 1H),
4.412 (br, 2H), 4.226 (br, 1H), 1.395 (s, 9H), 1.376−1.357 (d, 3H, J =
7.6 Hz); 13C NMR (100 MHz; CDCl3) 172.7, 155.6, 138.1, 128.7,
The authors declare no competing financial interest.
2382
dx.doi.org/10.1021/jo402872p | J. Org. Chem. 2014, 79, 2377−2383